ACADIA PHARMACEUTICALS INC Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Acadia Pharmaceuticals Inc Return On Assets for the quarter ending September 30, 2024 was 14.7 %.
  • Acadia Pharmaceuticals Inc annual Return On Assets for 2023 was -9.15 %, a 74.3% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Return On Assets for 2022 was -35.6 %, a 53.6% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Return On Assets for 2021 was -23.2 %, a 36.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -9.15 +26.4 +74.3% Jan 1, 2023 Dec 31, 2023
2022 -35.6 -12.4 -53.6% Jan 1, 2022 Dec 31, 2022
2021 -23.2 +13.3 +36.5% Jan 1, 2021 Dec 31, 2021
2020 -36.5 +0.97 +2.59% Jan 1, 2020 Dec 31, 2020
2019 -37.5 +29.1 +43.7% Jan 1, 2019 Dec 31, 2019
2018 -66.6 -0.73 -1.11% Jan 1, 2018 Dec 31, 2018
2017 -65.9 -13.8 -26.4% Jan 1, 2017 Dec 31, 2017
2016 -52.1 +10.9 +17.2% Jan 1, 2016 Dec 31, 2016
2015 -63 -36.5 -138% Jan 1, 2015 Dec 31, 2015
2014 -26.4 -4.68 -21.5% Jan 1, 2014 Dec 31, 2014
2013 -21.7 +24.4 +52.9% Jan 1, 2013 Dec 31, 2013
2012 -46.1 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.